Metabolomics profiling of metformin-mediated metabolic reprogramming bypassing AMPK alpha

Yan, M; Qi, H; Xia, T; Zhao, XJ; Wang, W; Wang, ZC; Lu, C; Ning, Z; Chen, H; Li, TM; Tekcham, DS; Liu, XM; Liu, J; Chen, D; Liu, XL; Xu, GW; Piao, HL

Xu, GW; Piao, HL (reprint author), Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, 457 Zhongshan Rd, Dalian 116023, Peoples R China.

METABOLISM-CLINICAL AND EXPERIMENTAL, 2019; 91 (): 18

Abstract

Background: Metformin is a first-line drug for treating type 2 diabetes and has gained considerable interest as a potential anticancer agent. Increasi......

Full Text Link